Drug-maker Novartis’ acquisition of gene therapy-focused firm AveXis for $8.7 billion and enterprise software major SAP’s $8 billion acquisition of survey and research software company Qualtrics were …
Drug-maker Novartis’ acquisition of gene therapy-focused firm AveXis for $8.7 billion and enterprise software major SAP’s $8 billion acquisition of survey and research software company Qualtrics were …